News and Trends 7 Jul 2022
French Juvisé buys gastro product in €400M finance deal
French pharmaceutical company, Juvisé has just bought worldwide commercial rights to Pylera from US biopharmaceutical company Abbvie. Juvisé negotiated financing of €400 million ($408 million) with Société Générale as part…
